Home
/
Gossamer Bio, Inc.
/
Financials
/
Quarterly
Gossamer Bio, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Gossamer Bio, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$13.29M
Nov 5, 2025
Q2
2025
Jun 30, 2025
$11.49M
Aug 5, 2025
Q1
2025
Mar 31, 2025
$9.89M
May 15, 2025
Q3
2025
Sep 30, 2024
$9.48M
Nov 5, 2025
Q2
2025
Jun 30, 2024
$95.84M
Aug 5, 2025
Q1
2025
Mar 31, 2024
$0
May 15, 2025
Q3
2024
Sep 30, 2023
$0
Nov 7, 2024
Q2
2024
Jun 30, 2023
$0
Aug 12, 2024
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($48.22M)
Nov 5, 2025
Q2
2025
Jun 30, 2025
($38.27M)
Aug 5, 2025
Q3
2025
Jun 30, 2025
($38.27M)
Nov 5, 2025
Q3
2025
Mar 31, 2025
($36.64M)
Nov 5, 2025
Q2
2025
Mar 31, 2025
($36.64M)
Aug 5, 2025
Q1
2025
Mar 31, 2025
($36.64M)
May 15, 2025
Q3
2025
Sep 30, 2024
($30.80M)
Nov 5, 2025
Q3
2025
Jun 30, 2024
$49.23M
Nov 5, 2025
Q2
2025
Jun 30, 2024
$49.23M
Aug 5, 2025
Q2
2025
Mar 31, 2024
($41.93M)
Aug 5, 2025
Q1
2025
Mar 31, 2024
($41.93M)
May 15, 2025
Q3
2025
Mar 31, 2024
($41.93M)
Nov 5, 2025
Q3
2024
Sep 30, 2023
($40.01M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($42.50M)
Aug 12, 2024
Q3
2024
Jun 30, 2023
($42.50M)
Nov 7, 2024
Q1
2024
Mar 31, 2023
($49.17M)
May 7, 2024
Q2
2024
Mar 31, 2023
($49.17M)
Aug 12, 2024
Q3
2024
Mar 31, 2023
($49.17M)
Nov 7, 2024
Q3
2023
Sep 30, 2022
($59.36M)
Nov 9, 2023
Q3
2023
Jun 30, 2022
($56.47M)
Nov 9, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($49.11M)
Nov 5, 2025
Q2
2025
Jun 30, 2025
($38.77M)
Aug 5, 2025
Q1
2025
Mar 31, 2025
($36.81M)
May 15, 2025
Q3
2025
Sep 30, 2024
($33.92M)
Nov 5, 2025
Q2
2025
Jun 30, 2024
$52.09M
Aug 5, 2025
Q1
2025
Mar 31, 2024
($41.96M)
May 15, 2025
Q3
2024
Sep 30, 2023
($40.49M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($46.30M)
Aug 12, 2024
Q1
2024
Mar 31, 2023
($47.94M)
May 7, 2024
Q3
2023
Sep 30, 2022
($56.02M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($53.87M)
Aug 8, 2023
Q1
2023
Mar 31, 2022
($54.34M)
May 9, 2023
Q3
2022
Sep 30, 2021
($55.66M)
Nov 3, 2022
Q2
2022
Jun 30, 2021
($55.60M)
Aug 9, 2022
Q1
2022
Mar 31, 2021
($53.20M)
May 10, 2022
Q3
2021
Sep 30, 2020
($53.57M)
Nov 8, 2021
Q2
2021
Jun 30, 2020
($65.34M)
Aug 9, 2021
Q1
2021
Mar 31, 2020
($54.97M)
May 6, 2021
Q3
2020
Sep 30, 2019
($49.99M)
Nov 10, 2020
Q2
2020
Jun 30, 2019
($46.35M)
Aug 11, 2020